IRFAC - Interface recherche fondamentale et appliquée en cancérologie

Type: Rapport d’évaluation des unités de recherche

Evaluation campaign: 2016-2017 (group C) - Published on: 26/07/2017

Institution(s) concerned: Université de Strasbourg , Institut national de la santé et de la recherche médicale - INSERM

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics

Name of unit teams: E1 - Emergence des Cellules Souches et Initiation Tumorale ; E2 - Réponse au Stress et Thérapies Innovantes

Keywords: Cancer ; gène homéotique ; stress cellulaire ; chimiothérapie ; hormonothérapie